UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,910,339 | -60.7% | 207,733 | -6.4% | 0.01% | -79.5% |
| Q4 2019 | $7,409,000 | +438.1% | 222,024 | +284.1% | 0.04% | +387.5% |
| Q3 2019 | $1,377,000 | -33.4% | 57,802 | +0.5% | 0.01% | -27.3% |
| Q2 2019 | $2,067,000 | -78.8% | 57,512 | -78.2% | 0.01% | -75.0% |
| Q1 2019 | $9,737,000 | +247.9% | 263,599 | +305.5% | 0.04% | +214.3% |
| Q4 2018 | $2,799,000 | +13.9% | 65,000 | +24.9% | 0.01% | +40.0% |
| Q3 2018 | $2,458,000 | – | 52,046 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 789,297 | $39,275,000 | 60.44% |
| Wildcat Capital Management, LLC | 251,459 | $12,513,000 | 9.57% |
| Consonance Capital Management LP | 1,487,491 | $74,018,000 | 4.77% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $124,394,000 | 3.53% |
| MEITAV INVESTMENT HOUSE LTD | 509,355 | $29,967,000 | 1.34% |
| DSAM Partners (London) Ltd | 127,588 | $6,349,000 | 1.28% |
| SHIKIAR ASSET MANAGEMENT INC | 48,125 | $2,395,000 | 1.00% |
| BANK HAPOALIM BM | 67,125 | $3,340,000 | 0.91% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $16,515,000 | 0.55% |
| Clal Insurance Enterprises Holdings Ltd | 310,000 | $15,426,000 | 0.40% |